186 related articles for article (PubMed ID: 8506453)
1. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.
Lammers GJ; Arends J; Declerck AC; Ferrari MD; Schouwink G; Troost J
Sleep; 1993 Apr; 16(3):216-20. PubMed ID: 8506453
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.
Scrima L; Hartman PG; Johnson FH; Hiller FC
Biol Psychiatry; 1989 Aug; 26(4):331-43. PubMed ID: 2669980
[TBL] [Abstract][Full Text] [Related]
3. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.
Boscolo-Berto R; Viel G; Montagnese S; Raduazzo DI; Ferrara SD; Dauvilliers Y
Sleep Med Rev; 2012 Oct; 16(5):431-43. PubMed ID: 22055895
[TBL] [Abstract][Full Text] [Related]
4. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.
Scrima L; Hartman PG; Johnson FH; Thomas EE; Hiller FC
Sleep; 1990 Dec; 13(6):479-90. PubMed ID: 2281247
[TBL] [Abstract][Full Text] [Related]
5. Narcolepsy in the older adult: epidemiology, diagnosis and management.
Chakravorty SS; Rye DB
Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
[TBL] [Abstract][Full Text] [Related]
6. Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated systematic review and meta-analysis.
Xu XM; Wei YD; Liu Y; Li ZX
Sleep Med; 2019 Dec; 64():62-70. PubMed ID: 31671326
[TBL] [Abstract][Full Text] [Related]
7. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.
Scharf MB; Brown D; Woods M; Brown L; Hirschowitz J
J Clin Psychiatry; 1985 Jun; 46(6):222-5. PubMed ID: 3888969
[TBL] [Abstract][Full Text] [Related]
8. Ritanserin improves sleep quality in narcolepsy.
Mayer G
Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
[TBL] [Abstract][Full Text] [Related]
9. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate.
Mamelak M
Prog Neurobiol; 2009 Oct; 89(2):193-219. PubMed ID: 19654034
[TBL] [Abstract][Full Text] [Related]
10. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
[TBL] [Abstract][Full Text] [Related]
11. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings.
Mamelak M; Scharf MB; Woods M
Sleep; 1986; 9(1 Pt 2):285-9. PubMed ID: 3704454
[TBL] [Abstract][Full Text] [Related]
12. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
[TBL] [Abstract][Full Text] [Related]
13. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
[TBL] [Abstract][Full Text] [Related]
14. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.
Mattarozzi K; Bellucci C; Campi C; Cipolli C; Ferri R; Franceschini C; Mazzetti M; Russo PM; Vandi S; Vignatelli L; Plazzi G
Sleep Med; 2008 May; 9(4):425-33. PubMed ID: 17681883
[TBL] [Abstract][Full Text] [Related]
15. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
J Clin Sleep Med; 2010 Dec; 6(6):596-602. PubMed ID: 21206549
[TBL] [Abstract][Full Text] [Related]
16. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy.
Broughton R; Mamelak M
Can J Neurol Sci; 1980 Feb; 7(1):23-31. PubMed ID: 7388696
[TBL] [Abstract][Full Text] [Related]
17. Selegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study.
Mayer G; Ewert Meier K; Hephata K
Clin Neuropharmacol; 1995 Aug; 18(4):306-19. PubMed ID: 8665543
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
[TBL] [Abstract][Full Text] [Related]
19. Ritanserin, a 5-HT2 receptor blocker, as add-on treatment in narcolepsy.
Lammers GJ; Arends J; Declerck AC; Kamphuisen HA; Schouwink G; Troost J
Sleep; 1991 Apr; 14(2):130-2. PubMed ID: 1678203
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of childhood narcolepsy. Can cataplexy be foretold?
Nevsimalova S; Jara C; Prihodova I; Kemlink D; Sonka K; Skibova J
Eur J Paediatr Neurol; 2011 Jul; 15(4):320-5. PubMed ID: 21345702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
